Exchange Traded Concepts’s Emergent Biosolutions EBS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-17,363
| Closed | -$364K | – | 1205 |
|
|
2022
Q3 | $364K | Buy |
17,363
+2,394
| +16% | +$50.2K | 0.01% | 580 |
|
|
2022
Q2 | $465K | Buy |
14,969
+2,535
| +20% | +$78.7K | 0.01% | 541 |
|
|
2022
Q1 | $511K | Buy |
+12,434
| New | +$511K | 0.01% | 649 |
|
|
2021
Q3 | – | Sell |
-4,233
| Closed | -$267K | – | 1143 |
|
|
2021
Q2 | $267K | Buy |
4,233
+216
| +5% | +$13.6K | 0.01% | 722 |
|
|
2021
Q1 | $373K | Sell |
4,017
-41
| -1% | -$3.81K | 0.01% | 641 |
|
|
2020
Q4 | $364K | Buy |
4,058
+458
| +13% | +$41.1K | 0.02% | 489 |
|
|
2020
Q3 | $372K | Buy |
+3,600
| New | +$372K | 0.02% | 377 |
|